The Economist Events' Pharma Summit 2015: The Dawn of a New Era

News provided by

Feb 23, 2015, 04:00 ET

LONDON, February 23, 2015 /PRNewswire/ --

Challenges impacting the world of pharma as well as the innovation required to face them

Tweet your questions ahead of the Pharma Summit 2015 via @EconomistEvents #pharmasummit

The Pharma Summit, now in its 21st year, is a must-attend event for industry leaders. The Summit provides a unique platform for stakeholders from across the industry to convene, share views and network with peers. This year's theme, 'The dawn of a new era', will observe the challenges the industry is facing as well as the innovation required to face them.

The annual Pharma Summit will be held in London on Thursday, February 26th2015 at The Radisson Blu Portman Hotel, London, from 9:00am to 5:30pm.

Kieran Murphy, a panel speaker and President and Chief Executive Officer, Life Sciences, GE Healthcare, commented:

"The technology promise in healthcare has never been more exciting, with the convergence of precision medicine, big data, analytics and the industrial internet, on top of breakthroughs in biologics, gene and immuno-therapies. Can the industry speed up and will payers pay up? This Pharma Summit will focus on how industry can innovate and collaborate to bring better, more effective and affordable medicine to more people, and still meet business objectives. I am looking forward to the meeting, the panels and the lively discussions it will provoke."

The Pharma Summit will address areas such as improving access and affordability of medicines, the immense differences between developed and emerging markets, technology in pharma, and enhancing partnerships across the ecosystem to benefit all. The event will bring together leading voices representing global pharmaceutical companies, patient associations, non-profit organisations, regulators and field experts to continue providing the most relevant insight, invaluable to the pharma industry.

Key speakers at the Summit include:

Guido Rasi, Principal Adviser in Charge of Strategy, European Medicines Agency
Andrew Hotchkiss, President, Australia, Canada and Europe, Lilly
Maureen Baker, Chair, Royal College of General Practitioners
Sir Michael Hirst, President, International Diabetes Federation
Manica Balasegaram, Executive Director - Access Campaign, Medecins Sans Frontieres
Richard Barker, Director, CASMI (Centre for the Advancement of Sustainable Medical Innovation)
Francois Bernard, Head of Market Access and Communications, MundiPharma
Alison Clough, Executive Director Commercial UK, Association of the British Pharmaceutical Industry
Sir Andrew Dillon, Chief Executive Officer, National Institute of Health and Clinical Excellence (NICE)
Jeremy Farrar, Director, Wellcome Trust
Patrick Flochel, Partner, Global Pharmaceutical Sector Leader, Global Life Sciences Centre, EY
Michel Goldman, former Executive Director, Innovative Medicines Initiative (IMI)
Matthias Gottwald, Head Research and Development Policy and Networking, Bayer Healthcare Pharmaceuticals
Janet Hammond, Global Head and Senior Vice-president, Infectious Diseases Discovery and Translational Area, Roche Pharma Research and Early Development
James Heywood, Chairman and Co-founder, Patients Like Me
Heidi Hunter, Head of Biosimilars Business Unit, Boehringer-Ingelheim
Stefan Kapferer, Deputy Secretary-General, OECD
Nuria Mas, Professor of Economics, IESE Business School
David McMillan, Chief Executive Officer, Europe, Aviva
Duncan Moore, Partner, East West Capital Partners
Jeremy Morgan, International Vice-president Diabetes, Lilly
Kieran Murphy, President & Chief Executive Officer, GE Healthcare Life Sciences
Vivek Muthu, Chair, Economist Intelligence Unit Healthcare
Vas Narasiham, Global Head of Development, Novartis
Diem Nguyen, General Manager, LOE Portfolio Head, US Promoted Brands, Pfizer
Jim O'Neill, Chair, Review on Antimicrobial Resistance
David Solomon, Chief Executive Officer, Bionor Pharma
Adrian Thomas, Vice-president Global Market Access, Commercial Strategy Operations and Global Public Health, Janssen
Bart Vannieuwenhuyse, Senior Director of Health Information Sciences, Janssen
John Watson, Deputy Chief Medical Officer, UK Department of Health
Pascale Witz, Executive Vice-president Global Divisions & Strategic Development, Sanofi

For more information and to view the full programme please visit: http://www.pharmasummit.economist.com

Follow the Pharma Summit via @EconomistEvents #pharmasummit on Twitter to get the latest updates, submit your questions, and join in with discussions on the day.

About The Economist Events

The Economist Events' philosophy is to tackle issues with a forward-looking, uniquely global perspective. We aim to create events for the intellectually curious: people who enjoy ideas and who are passionate about the issues that define our world.

Attend our events: http://www.economistinsights.com/events

Platinum sponsor: EY

EY is a global leader in assurance, tax, transaction and advisory services. The insights and quality services we deliver help build trust and confidence in the capital markets and in economies the world over. We develop outstanding leaders who team to deliver on our promises to all of our stakeholders. In so doing, we play a critical role in building a better working world for our people, for our clients and for our communities.

EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. For more information about our organization, please visit ey.com.

This news release has been issued by EYGM Limited, a member of the global EY organization that also does not provide any services to clients.

Gold sponsor: IESE
IESE Business School, the graduate school of management of the University of Navarra, is consistently ranked among the world's leading business schools. Highly international, the school is committed to the education and development of responsible business leaders worldwide. It offers high calibre degree and executive education programmes, and conducts rigorous research initiatives that are global in scope.

In addition to world class campuses in Barcelona and Madrid, the school has a centre in New York City and offices in London, Munich and Sao Paulo. It also delivers programmes at numerous other locations, including Miami, Dubai and Shanghai. IESE launched Europe's first two-year MBA programme in 1964 under the guidance of Harvard Business School and it also pioneered the concept of executive education for business leaders in Europe.

About Consilium Strategic Communications

Consilium Strategic Communications is a global leader in providing trusted, healthcare-focused strategic IR and financial PR counsel to corporations, Boards, senior decision makers and executives. From offices in Europe and USA, Consilium's senior team provides cross-border comprehensive financial and corporate healthcare communications advice to some of the world's most prominent and innovative corporations around-the-clock. The Company has established deep knowledge across all areas of the global healthcare sector through broad experience in representing international clients spanning the Fortune 500, FTSE100, FTSEurofirst 300, FTSE250, Euronext and AIM through to discrete specialist reputation management and crisis projects. For more information please visit our website at http://www.consilium-comms.com.

Press enquiries
For further information on event registration or to request interviews with any of the speakers at the Pharma Summit 2015, please contact Consilium Strategic Communications, Official Press Office for The Economist Healthcare Events:

Lindsey Neville or Liza Carr
Email: [email protected]
Tel: +44(0)20-3709-5700

For general queries or further information about the event please call +44(0)207-576-8118 or e-mail [email protected]

Want more from The Economist Events?
Join us on Twitter: @EconomistEvents